Vanguard Group
ONEM

Vanguard Group’s 1Life Healthcare ONEM Stock Holding History

Vanguard Group’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17,071,447
Closed -$285M – 4621
2022
Q4 		$285M Buy
17,071,447
+794,124
+5% +$13.4M 0.01% 1224
2022
Q3 		$279M Buy
16,277,323
+123,246
+0.8% +$1.93M 0.01% 1185
2022
Q2 		$127M Buy
16,154,077
+1,705,274
+12% +$14.7M ﹤0.01% 1680
2022
Q1 		$160M Buy
14,448,803
+324,722
+2% +$3.64M ﹤0.01% 1687
2021
Q4 		$248M Buy
14,124,081
+4,246,617
+43% +$82.4M 0.01% 1473
2021
Q3 		$200M Buy
9,877,464
+1,001,497
+11% +$25.7M 0.01% 1610
2021
Q2 		$293M Buy
8,875,967
+1,037,900
+13% +$39.2M 0.01% 1364
2021
Q1 		$306M Buy
7,838,067
+675,331
+9% +$31.7M 0.01% 1293
2020
Q4 		$313M Buy
7,162,736
+623,582
+10% +$21.3M 0.01% 1169
2020
Q3 		$185M Buy
6,539,154
+3,756,643
+135% +$119M 0.01% 1330
2020
Q2 		$101M Buy
2,782,511
+1,385,487
+99% +$39M ﹤0.01% 1673
2020
Q1 		$25.4M Buy
+1,397,024
New +$30.6M ﹤0.01% 2186

Vanguard Group's ONEM Position: Q1 2023 in Review

Vanguard Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 17,071,447 shares — an estimated $285M sold.

Vanguard Group first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $313M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Vanguard Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Vanguard Group sold 17,071,447 1Life Healthcare shares in Q1 2023, an estimated $285M.
  • Vanguard Group first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Vanguard Group's 1Life Healthcare position peaked at $313M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.